Evidence map›Paper›PMID 35170978›Full record

ArticleJournal of the American Heart Association2022

Risk of Parkinson Disease and Secondary Parkinsonism in Myocardial Infarction Survivors.

Jens Sundbøll, Szimonetta Komjáthiné Szépligeti, Péter Szentkúti, Kasper Adelborg, Erzsébet Horváth-Puhó, Lars Pedersen, Victor W Henderson, Henrik Toft Sørensen

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Observational
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Jens SundbøllDepartment of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.ORCID 0000-0002-1276-1419
Szimonetta Komjáthiné SzépligetiDepartment of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.
Péter SzentkútiDepartment of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.
Kasper AdelborgDepartment of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.ORCID 0000-0001-5639-7252
Erzsébet Horváth-PuhóDepartment of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.ORCID 0000-0002-3594-2212
Lars PedersenDepartment of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.
Victor W HendersonDepartment of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.ORCID 0000-0003-1198-9240
Henrik Toft SørensenDepartment of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.ORCID 0000-0003-4299-7040
Aarhus University Hospital · DK

Funding

Stanford Alzheimer's Disease Research CenterAdmin Supp: Developing iPSC models for AD and PDP30AG066515 · NIA · STANFORD UNIVERSITY · PI ELIZABETH MORMINO · 2020 to 2026
$29.0M
NIA NIH HHS P30 AG066515
6 · The paper itself

Abstract

Background In addition to primary neurodegenerative processes, vascular disorders, such as stroke, can lead to parkinsonism. However, some cardiovascular risk factors, such as smoking and elevated cholesterol levels, are associated with reduced risk of Parkinson disease. We examined the risk of Parkinson disease and secondary parkinsonism in 1-year survivors of myocardial infarction (MI). Methods and Results We conducted a nationwide population-based matched cohort study using Danish medical registries from 1995 to 2016. We identified all patients with a first-time MI diagnosis and sampled a sex-, age-, and calendar year-matched general population comparison cohort without MI. Cox regression analysis was used to compute adjusted hazard ratios (aHRs) for Parkinson disease and secondary parkinsonism, controlled for matching factors and adjusted for relevant comorbidities and socioeconomic factors. We identified 181 994 patients with MI and 909 970 matched comparison cohort members (median age, 71 years; 62% men). After 21 years of follow-up, the cumulative incidence was 0.9% for Parkinson disease and 0.1% for secondary parkinsonism in the MI cohort. Compared with the general population cohort, MI was associated with a decreased risk of Parkinson disease (aHR, 0.80; 95% CI, 0.73-0.87) and secondary parkinsonism (aHR, 0.72; 95% CI, 0.54-0.94). Conclusions MI was associated with a 20% decreased risk of Parkinson disease and 28% decreased risk of secondary parkinsonism. Reduced risk may reflect an inverse relationship between cardiovascular risk factors and Parkinson disease.

Indexed as

Myocardial InfarctionParkinson DiseaseParkinson Disease, SecondaryAgedCohort StudiesDenmarkFemaleHumansMaleRisk FactorsSurvivorsepidemiologymyocardial infarctionParkinson disease

Identifiers

PMID35170978
PMCPMC9075091
OpenAlexW4213131616

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.